Exelixis
EXEL
#1681
Rank
ยฃ9.03 B
Marketcap
ยฃ33.56
Share price
-1.88%
Change (1 day)
25.26%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: ยฃ9.03 Billion

As of December 2025 Exelixis has a market cap of ยฃ9.03 Billion. This makes Exelixis the world's 1681th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ9.03 B17.42%
2024ยฃ7.69 B31.39%
2023ยฃ5.85 B36.92%
2022ยฃ4.27 B-0.19%
2021ยฃ4.28 B-6.2%
2020ยฃ4.56 B11.89%
2019ยฃ4.08 B-12.14%
2018ยฃ4.64 B-30.17%
2017ยฃ6.65 B89.96%
2016ยฃ3.50 B303.8%
2015ยฃ0.86 B378.84%
2014ยฃ0.18 B-73.58%
2013ยฃ0.68 B32.03%
2012ยฃ0.51 B25.77%
2011ยฃ0.41 B-28.95%
2010ยฃ0.58 B18.25%
2009ยฃ0.49 B35.89%
2008ยฃ0.36 B-20.51%
2007ยฃ0.45 B3.17%
2006ยฃ0.44 B-3.19%
2005ยฃ0.45 B22.77%
2004ยฃ0.37 B32.07%
2003ยฃ0.28 B-5.17%
2002ยฃ0.29 B-53.96%
2001ยฃ0.64 B40.55%
2000ยฃ0.45 B

End of Day market cap according to different sources

On Dec 29th, 2025 the market cap of Exelixis was reported to be:

ยฃ8.99 Billion
by Nasdaq info icon info icon
ยฃ9.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
ยฃ73.51 B 713.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ86.64 B 859.10%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ196.98 B 2,080.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ81.47 B 801.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ131.29 B 1,353.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ369.89 B 3,994.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ105.14 B 1,063.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
ยฃ9.94 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ0.38 B-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA